| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.44 | 2e-38 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-19 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.3 | 5e-18 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-16 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.38 | 5e-13 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-10 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.32 | 4e-09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |